ÌÇÐÄvlog´«Ã½

FeNO Measuring Devices Market Analysis

The FeNO Measuring Devices Market size is estimated at USD 90.32 million in 2024, and is expected to reach USD 162.18 million by 2029, growing at a CAGR of 12.42% during the forecast period (2024-2029).

The market for FeNO (fractional exhaled nitric oxide) measuring devices is driven by the increasing prevalence of respiratory disorders, such as asthma and chronic obstructive pulmonary disease (COPD) globally. In addition, continuous advancements in FeNO technologies encourage healthcare providers to integrate these devices into clinical practice, thereby driving market growth.

The high prevalence of asthma and COPD, exacerbated by factors like urbanization, pollution, and lifestyle changes, is a primary driver for the FeNO measuring devices market. These devices help in early diagnosis and personalized treatment planning. For instance, according to the data published by the Australian Institute of Health and Welfare in June 2024, asthma represented 2.5% of the overall disease burden in Australia in 2023. In addition, asthma constituted 4.4% of the non-fatal burden and 0.3% of the fatal burden in Australia in 2023. Additionally, within the respiratory disease group, asthma accounted for 52% of non-fatal burden in Australia in 2023. This shows the high burden of asthma, which is expected to increase the need for FeNO devices for diagnosis and management, thereby boosting market growth.

Furthermore, complimentary technological advancements in integrating FeNO measurements with other healthcare solutions are expected to increase the demand for FeNO devices over the forecast period. For instance, in February 2024, ZEPHYRx and NIOX collaborated to incorporate NIOX's FeNO technology into the ZEPHYRx Respiratory Cloud Platform. This integration aims to streamline clinical research by consolidating various respiratory endpoints into a reliable source. The ZEPHYRx platform seamlessly captures data from NIOX devices, making it instantly available on the Provider Dashboard. Hence, technological advancements expand the application of FeNO devices, which is expected to see significant growth in the market over the forecast period.

Consequently, as respiratory diseases become more prevalent and technology advances, the demand for FeNO measuring devices surges, driving market growth throughout the forecast period. However, the high cost of these devices is expected to hinder market growth over the forecast period.

FeNO Measuring Devices Market Trends

Electrochemical Technology Segment is Expected to Have Significant Growth in the Market Over the Forecast Period

FeNO Measuring Devices Industry Segmentation

As per the report's scope, FeNO (fractional exhaled nitric oxide) measuring devices are medical instruments used to quantify the concentration of nitric oxide (NO) in a patient's exhaled breath. These devices are increasingly playing a key role in diagnosing, managing, and monitoring conditions like asthma and COPD by measuring the level of nitric oxide in exhaled breath, which correlates with airway inflammation.

The FeNO measuring devices market is segmented by technology, type of device, application, end user, and geography. By technology, the market is bifurcated into chemiluminescence and electrochemical. The market is segmented by measuring devices into handheld FeNO measuring devices and tabletop FeNO measuring devices. Based on application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and other applications. By end user, the market is segmented into hospitals and clinics, diagnostic centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Market sizing and forecasts were made for each segment based on value (USD).